Document Detail


Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
MedLine Citation:
PMID:  9208999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, and were compared to 341 age- and sex-matched controls. The aim of the study was to determine the prevalence and clinical characteristics of resistance to activated protein C (APC), a defect shown to have different prevalences in different ethnic groups and to be associated with an increased risk of thrombosis. Seventy-three (15%) patients had both APC resistance and the 1691 G to A factor V gene mutation, compared to 6/341 (2%) controls. Seven patients had antithrombin deficiency (1.4%), 11 had protein C deficiency (2.2%), and 4 had protein S deficiency (0.8%). The relative risk of thrombosis in APC-resistant patients was 9.4. Resistance to APC was associated mainly with venous thrombosis, the most frequent being deep-vein thrombosis of the lower limbs. Fifty-eight percent of APC-resistant patients had an associated risk factor at the first thrombotic event: pregnancy and oral contraceptive intake were associated with the first thrombotic episode in 35% and 30% of women, respectively. APC resistance is the most frequent defect of blood coagulation in the general population and in the unselected thrombotic population studied by us.
Authors:
E M Faioni; C Razzari; I Martinelli; D Panzeri; F Franchi; P M Mannucci
Related Documents :
18676389 - A critical review of thromboembolic complications associated with central venous cathet...
19374679 - Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observ...
9152919 - Migration of central venous catheters: implications for initial catheter tip positioning.
19276139 - Retrospective review of hemoglobin and/or hematocrit levels with occurrence of thrombos...
14603199 - Symptoms of chronic venous disease and association with systemic inflammatory markers.
11174739 - Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assi...
1157549 - Volume-controlled lung lavage in a woman with cystic fibrosis.
21932989 - The use of a desktop scanning electron microscope as a diagnostic tool in studying fibr...
11756989 - Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immuno...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of hematology     Volume:  55     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-07-24     Completed Date:  1997-07-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  59-64     Citation Subset:  IM    
Affiliation:
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, I.R.C.C.S. Maggiore Hospital and Institute of Internal Medicine, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Coagulation Disorders / physiopathology*
Contraceptives, Oral / adverse effects
Enzyme Activation
Factor V / genetics*
Female
Humans
Male
Middle Aged
Point Mutation
Pregnancy
Pregnancy Complications, Hematologic
Protein C / metabolism*
Protein C Deficiency
Protein S Deficiency / complications
Risk Factors
Thrombosis / physiopathology*
Chemical
Reg. No./Substance:
0/Contraceptives, Oral; 0/Protein C; 9001-24-5/Factor V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption.
Next Document:  Prenatal diagnosis of thalassemia in the Chinese.